GRAS INDEPENDENT DETERMINATIONS BY MANUFACTURERS WILL BE CONSIDERED BY FDA
This article was originally published in The Tan Sheet
GRAS INDEPENDENT DETERMINATIONS BY MANUFACTURERS WILL BE CONSIDERED BY FDA in determining whether a dietary supplement ingredient is safe, the agency said in the final rule for dietary supplement health claims published in the Jan. 4 Federal Register. FDA said it "intends to consider the basis of manufacturers' independent determinations [when] submitted with petitions for health claims and may use its discretion to accept, without formal affirmation, the independent determination of GRAS [generally recognized as safe] where FDA believes such action would be appropriate."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC